Fund shareholders of TARSUS PHARMACEUTICALS INC
ISIN US87650L1035 · United States
- Fund shareholders
- 235
- Of which ETFs
- 47 188 other funds
- Value held
- ≈ 763.1M $ 759.2M $ · 37.3M SEK · 3.5K €
- Share of capital
- 28.2 % of 43.9M shares on Jul 30, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| TIFF MULTI-ASSET FUND TIFF Multi-Asset Fund | 1,092 | 68.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 1,057 | 66.5K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| HUSSMAN STRATEGIC ALLOCATION FUND Hussman Investment Trust | 1,000 | 62.9K $ | 0.26 % | 0.00 % | as of Jun 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 954 | 60K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Eventide Small Cap ETF Strategy Shares | 952 | 56.2K $ | 0.16 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Innovator U.S. Small Cap Managed Floor ETF Innovator ETFs Trust | 932 | 55K $ | 0.06 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Federated Hermes Global Allocation Fund Federated Hermes Global Allocation Fund | 911 | 54.1K $ | 0.02 % | 0.00 % | as of May 31, 2026 ↗ |
| MFS Global Alternative Strategy Fund MFS Series Trust XV | 729 | 43K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 685 | 40.4K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 653 | 41.1K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 539 | 31.8K $ | 0.05 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 501 | 31.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 457 | 28.8K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 248 | 15.6K $ | 0.27 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 228 | 13.5K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 225 | 14.2K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 222 | 14K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 212 | 13.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 201 | 12.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 187 | 11.1K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 172 | 10.8K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 124 | 7.3K $ | 0.07 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 114 | 6.7K $ | 0.04 % | 0.00 % | as of Jul 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 112 | 7K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 104 | 6.5K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 69 | 4.3K $ | 0.12 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 62 | 3.9K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Core ETF Fidelity Covington Trust | 42 | 2.6K $ | 0.00 % | as of Jun 30, 2026 ↗ | |
| ProShares Hedge Replication ETF ProShares Trust | 37 | 2.2K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 35 | 2.1K $ | 0.03 % | 0.00 % | as of Jul 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 34 | 2K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Avantis U.S. Quality ETF American Century ETF Trust | 18 | 1.1K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 12 | 755.3 $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 12 | 712.8 $ | 0.06 % | 0.00 % | as of May 31, 2026 ↗ |
| DIRECTOR GROWTH, FI INVERSIS GESTIÓN, S.A., SGIIC | 3.5K € | 0.10 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Pharmaceuticals ETF Invesco Exchange-Traded Fund Trust | 2.53 % | as of Jul 31, 2026 ↗ |
| Nomura Small Cap Growth Fund IVY FUNDS | 1.84 % | as of Jun 30, 2026 ↗ |
| SFT Nomura Small Cap Growth Fund Securian Funds Trust | 1.84 % | as of Jun 30, 2026 ↗ |
| Nomura VIP Small Cap Growth Series Ivy Variable Insurance Portfolios | 1.84 % | as of Jun 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.61 % | as of May 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF SPDR SERIES TRUST | 1.57 % | as of Jun 30, 2026 ↗ |
| PROFUND VP PHARMACEUTICALS ProFunds | 1.52 % | as of Jun 30, 2026 ↗ |
| Lannebo Global Småbolag Lannebo Kapitalförvaltning AB | 1.51 % | as of Mar 31, 2026 ↗ |
| Baird Small/Mid Cap Growth Fund Baird Funds Inc | 1.46 % | as of Jun 30, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.31 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 232 | -6 | 12,311,637 | +2.4 % |
| 2026Q2 | 238 | +6 | 12,024,796 | -5.6 % |
| 2026Q1 | 232 | +18 | 12,738,720 | +5.3 % |
| 2025Q4 | 214 | +11 | 12,099,759 | +1.0 % |
| 2025Q3 | 203 | +6 | 11,976,768 | +5.0 % |
| 2025Q2 | 197 | +21 | 11,407,200 | +8.8 % |
| 2025Q1 | 176 | +1 | 10,488,147 | +10.5 % |
| 2024Q4 | 175 | +4 | 9,493,528 | +13.3 % |
| 2024Q3 | 171 | +12 | 8,381,758 | +22.3 % |
| 2024Q2 | 159 | +29 | 6,854,894 | +26.5 % |
| 2024Q1 | 130 | +2 | 5,417,163 | +13.8 % |
| 2023Q4 | 128 | 4,761,687 |
Institutional managers
246 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Deep Track Capital, LP | 3,600,000 | 252.5M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 3,552,612 | 249.2M $ | as of Mar 31, 2026 |
| RTW INVESTMENTS, LP | 3,346,025 | 234.7M $ | as of Mar 31, 2026 |
| Paradigm Biocapital Advisors LP | 2,562,154 | 179.7M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 2,240,963 | 157.2M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,944,272 | 136.4M $ | as of Mar 31, 2026 |
| JENNISON ASSOCIATES LLC | 1,712,124 | 120.1M $ | as of Mar 31, 2026 |
| Assenagon Asset Management S.A. | 1,280,194 | 89.8M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,194,377 | 83.8M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 1,188,624 | 83.4M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,121,091 | 78.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 978,212 | 68.6M $ | as of Mar 31, 2026 |
| Driehaus Capital Management LLC | 926,125 | 65M $ | as of Mar 31, 2026 |
| LORD, ABBETT & CO. LLC | 842,313 | 59.1K $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 791,146 | 55.5M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 742,497 | 52.1M $ | as of Mar 31, 2026 |
| FMR LLC | 733,334 | 51.4M $ | as of Mar 31, 2026 |
| Frazier Life Sciences Management, L.P. | 728,644 | 51.1M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 564,579 | 39.6M $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 545,351 | 38.3M $ | as of Mar 31, 2026 |
| TORONTO DOMINION BANK | 510,253 | 35.8M $ | as of Mar 31, 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 499,853 | 35.1M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 439,626 | 30.8M $ | as of Mar 31, 2026 |
| LOOMIS SAYLES & CO L P | 407,836 | 28.6M $ | as of Mar 31, 2026 |
| TimesSquare Capital Management, LLC | 388,590 | 27.3M $ | as of Mar 31, 2026 |
Declared shareholders of TARSUS PHARMACEUTICALS INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| JANUS HENDERSON GROUP Ltd. | 6.50 % | 2,808,796 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of TARSUS PHARMACEUTICALS INC". https://titelia.com/en/stocks/tarsus-pharmaceuticals-inc-US87650L1035